Skip to Main content Skip to Navigation
Journal articles

EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer

Abstract : Background: Lung cancer is the leading cause of brain metastases (BM). The identification of driver oncogenes and matched targeted therapies has improved outcome in non-small cell lung cancer (NSCLC) patients; however, a better understanding of BM molecular biology is needed to further drive the process in this field. Methods: In this observational study, stage IV NSCLC patients tested for EGFR and KRAS mutations were selected, and BM incidence, recurrence and patients' outcome were assessed. Results: A total of 144 patients (142 Caucasian and two Asian) were selected, including 11.27% with EGFR-mutant and 33.10% with KRAS-mutant tumors, and 57.04% patients had developed BM. BM incidence was more frequent in patients with EGFR mutation according to multivariate analyses (MVA) (Odds ratio OR = 8.745 [1.743–43.881], p = 0.008). Among patients with treated BM, recurrence after local treatment was less frequent in patients with KRAS mutation (OR = 0.234 [0.078–0.699], p = 0.009). Among patients with untreated BM, overall survival (OS) was shorter for patients with KRAS mutation according to univariate analysis (OR = 7.130 [1.240–41.012], p = 0.028), but not MVA. Conclusions: EGFR and KRAS mutations have a predictive role on BM incidence, recurrence and outcome in Caucasian NSCLC patients. These results may impact the routine management of disease in these patients. Further studies are required to assess the influence of other biomarkers on NSCLC BM.
Document type :
Journal articles
Complete list of metadatas

Cited literature [41 references]  Display  Hide  Download

https://hal-amu.archives-ouvertes.fr/hal-01477442
Contributor : l'Houcine Ouafik <>
Submitted on : Monday, February 27, 2017 - 1:55:39 PM
Last modification on : Friday, October 23, 2020 - 4:51:33 PM

File

ijms-17-02132-v2.pdf
Publisher files allowed on an open archive

Identifiers

Collections

Citation

Pascale Tomasini, Cindy Serdjebi, Nataliya Khobta, Philippe Metellus, l'Houcine Ouafik, et al.. EGFR and KRAS Mutations Predict the Incidence and Outcome of Brain Metastases in Non-Small Cell Lung Cancer. International Journal of Molecular Sciences, MDPI, 2016, 17 (12), pp.2132. ⟨10.3390/ijms17122132⟩. ⟨hal-01477442⟩

Share

Metrics

Record views

342

Files downloads

433